About MAXONA Pharmaceuticals
MAXONA Pharmaceuticals is a private company based in Malvern, Pennsylvania. It has reported $11,333,673 raised in two offerings on Form D since May 2021. Its chief executive is Shahin Fatholahi.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 4, 2025 | Jun 13, 2025amended Aug 14, 2026 | $5,778,673of $12.0M target | 56 | $103K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Apr 9, 2021 | May 5, 2021 | $5,555,000of $10.0M target | 34 | $163K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $11,333,673 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on MAXONA Pharmaceuticals's Form D filed Aug 14, 2026.
